Stockscreener 앱 받기
3.76
0.53%
-0.02
시간 외 거래:
3.70
-0.06
-1.60%
전일 마감가:
$3.78
열려 있는:
$3.78
하루 거래량:
213.52K
Relative Volume:
0.18
시가총액:
$6.18M
수익:
$14.91M
순이익/손실:
$-3.56M
주가수익비율:
-1.5289
EPS:
-2.4593
순현금흐름:
$-1.37M
1주 성능:
-1.83%
1개월 성능:
-5.76%
6개월 성능:
+11.24%
1년 성능:
+36.73%
1일 변동 폭
$3.37
$3.8399
1주일 범위
$3.37
$4.10
52주 변동 폭
$1.75
$6.9199
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
SNOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.76 | 6.24M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.63B | 260.53M | 4.77B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
소노마 파머 주식(SNOA)의 최신 뉴스
What analysts say about Sonoma Pharmaceuticals Inc stockSwing Trading Ideas & Free Superior Stock Performance - earlytimes.in
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results - ACCESS Newswire
Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales - TradingView
Sonoma Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Sentiment analysis tools applied to Sonoma Pharmaceuticals Inc.2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock responds to job market shifts2025 AllTime Highs & Verified Short-Term Plans - newser.com
Sonoma Pharmaceuticals Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockWeekly Stock Recap & Real-Time Volume Analysis - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.Earnings Risk Summary & Reliable Trade Execution Plans - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.Earnings Risk Report & High Return Stock Watch Alerts - newser.com
Predicting Sonoma Pharmaceuticals Inc. trend using moving averages2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stockJuly 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. stock a dividend growth opportunityCEO Change & Long-Term Capital Growth Strategies - newser.com
Why Sonoma Pharmaceuticals Inc. stock is favored by top institutionsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
How Sonoma Pharmaceuticals Inc. stock benefits from tech adoptionEntry Point & Expert Curated Trade Setup Alerts - newser.com
Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain margin levels2025 Major Catalysts & Safe Capital Growth Plans - newser.com
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockEarnings Growth Report & Pattern Based Trade Signal System - newser.com
Is Sonoma Pharmaceuticals Inc. stock a buy for dividend growthShort Setup & Long Hold Capital Preservation Plans - newser.com
Is Sonoma Pharmaceuticals Inc. stock gaining market shareJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyMarket Risk Summary & Proven Capital Preservation Methods - newser.com
Analyzing net buyer seller activity in Sonoma Pharmaceuticals Inc.Weekly Trend Summary & Daily Price Action Insights - newser.com
Will Sonoma Pharmaceuticals Inc. stock attract more institutional investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Does Sonoma Pharmaceuticals Inc. stock trade at a discount to peersGold Moves & Real-Time Stock Entry Alerts - newser.com
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.60%
0.45%
자본화:
|
볼륨(24시간):